Subthreshold rejection activity in many kidney transplants currently classified as having no rejection
Philip F Halloran,Katelynn S Madill-Thomsen,Georg Böhmig,Jonathan Bromberg,Klemens Budde,Meagan Barner,Martina Mackova,Jessica Chang,Gunilla Einecke,Farsad Eskandary,Gaurav Gupta,Marek Myślak,Ondrej Viklicky,Enver Akalin,Tarek Alhamad,Sanjiv Anand,Miha Arnol,Rajendra Baliga,Mirosław Banasik,Adam Bingaman,Chris Blosser,Daniel Brennan,Andrzej Chamienia,Kevin Chow,Michał Ciszek,Declan de Freitas,Dominika Dęborska-Materkowska,Alicja Debska-Ślizień,Arjang Djamali,Leszek Domański,Magdalena Durlik,Richard Fatica,Iman Francis,Justyna Fryc,John Gill,Jagbir Gill,Maciej Glyda,Sita Gourishankar,Ryszard Grenda,Marta Gryczman,Petra Hruba,Peter Hughes,Arskarapurk Jittirat,Zeljka Jurekovic,Layla Kamal,Mahmoud Kamel,Sam Kant,Bertram Kasiske,Nika Kojc,Joanna Konopa,James Lan,Roslyn Mannon,Arthur Matas,Joanna Mazurkiewicz,Marius Miglinas,Thomas Mueller,Seth Narins,Beata Naumnik,Anita Patel,Agnieszka Perkowska-Ptasińska,Michael Picton,Grzegorz Piecha,Emillio Poggio,Silvie Rajnochová Bloudíčkova,Milagros Samaniego-Picota,Thomas Schachtner,Sung Shin,Soroush Shojai,Majid Sikosana,Janka Slatinská,Katarzyna Smykal-Jankowiak,Ashish Solanki,Željka Veceric Haler,Ksenija Vucur,Matthew R Weir,Andrzej Wiecek,Zbigniew Włodarczyk,Harold Yang,Ziad Zaky
DOI: https://doi.org/10.1016/j.ajt.2024.07.034
2024-08-06
Abstract:Most kidney transplant patients who undergo biopsies are classified as having no rejection based on consensus thresholds. However, we hypothesized that because these patients have normal adaptive immune systems, T cell-mediated rejection (TCMR) and antibody-mediated rejection (ABMR) may exist as subthreshold activity in some transplants currently classified as no rejection. To examine this question, we studied genome-wide microarray results from 5086 kidney transplant biopsies (4170 patients). An updated archetypal analysis designated 56% of biopsies as no rejection. Subthreshold molecular TCMR and/or ABMR activity molecular activity was detectable as elevated classifier scores in many biopsies classified as no rejection, with ABMR activity in many TCMR biopsies and TCMR activity in many ABMR biopsies. In biopsies classified as no rejection histologically and molecularly, molecular TCMR classifier scores correlated with increases in histologic TCMR features and molecular injury, lower eGFR, and higher risk of graft loss, and molecular ABMR activity correlated with increased glomerulitis and donor-specific antibody. No rejection biopsies with high subthreshold TCMR or ABMR activity had a higher probability of having TCMR or ABMR respectively diagnosed in a future biopsy. We conclude that many kidney transplant recipients have unrecognized subthreshold TCMR or ABMR activity, with significant implications for future problems.